Effectiveness of pegylated interferon [peginterferon-alpha-2a] plus ribavirin in the treatment of active and past intravenous drug users infected with hepatitis C
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2013
At a glance
- Drugs Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 01 Aug 2013 Results published in Clinical Infectious Diseases.
- 03 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 03 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.